Partial and weak oestrogenicity of the red wine constituent resveratrol: Consideration of its superagonist activity in MCF-7 cells and its suggested cardiovascular protective effects

Journal of Applied Toxicology

Volumn 19, Issue 1, 1999, Pages 39-45

  Ashby, J ^a   Tinwell, H ^a   Pennie, W ^a   Brooks, A N ^a   Lefevre, P A ^a   Beresford, N ^b   Sumpter, J P ^b  

^a ASTRAZENECA   (United Kingdom)

^b BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

In vitro; In vivo; Oestrogenicity evaluation; Resveratrol

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ESTROGEN RECEPTOR; PHYTOESTROGEN; RESVERATROL;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOASSAY; CARDIOVASCULAR EFFECT; CELL STRAIN COS1; CELL STRAIN MCF 7; FEMALE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS; WINE; YEAST;

ANIMALS; BINDING, COMPETITIVE; CARDIOVASCULAR SYSTEM; CELL LINE; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGENS; FEMALE; FUNGI; PLASMIDS; RATS; RECEPTORS, ESTROGEN; STILBENES; TRANSFECTION; UTERUS; WINE;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0032949663     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1263(199901/02)19:1<39::AID-JAT534>3.0.CO;2-M     Document Type: Article

References (11)

1. B. D. Gehm, J. M. McAndrews, P. Y. Chien and J. L. Jameson, Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc. Natl. Acad. Sci. USA 94, 14138-14143 (1997).
2. D. M. Goldberg, S. Hahn and J. G. Parkes, Beyond alcohol: beverage consumption and cardiovascular mortality. Clin. Chim. Acta 237, 155-187 (1995).
3. C. R. Pace-Asciak, O. Rounova, S. E. Hahn, E. P. Diaman and D. M. Goldberg, Wines and grape jucies as modulators of platelet aggregation in healthy human subjects. Clin. Chim. Acta 246, 163-182 (1996).
4. K. S. Korach, Estrogen action in the mouse uterus: characterization of the cytosol and nuclear receptor systems. Endocrinology 104, 1324-1332 (1979).
5. M. D. Shelby, R. R. Newbould, D. B. Tully, K. Chae and V. L. Davis, Assessing environmental chemicals for estrogenicity using a combination of in vitro and in vivo assays. Environ. Health Perspect. 104, 1296-1300 (1996).
6. E. J. Routledge and J. P. Sumpter, Estrogenic activity of surfactants and their degradation products assessed using a recombinant yeast screen. Environ. Toxicol. Chem. 15, 241-248 (1996).
7. S. Green, P. Walter, V. Kumar, A. Krust, J. M. Bornert, P. Argos and P. Chambon, Human estrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (London) 320, 134-139 (1986).
8. G. G. Kuiper, E. Enmark, M. Pelto-Huikko, S. Nilsson and J. A. Gustafsson, Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci USA 93, 5925-5930 (1996).
9. J. Odum, P. A. Lefevre, S. Tittensor, D. Paton, C. A. Harris, N. A. Beresford, J. P. Sumpter and J. Ashby, The rodent uterotrophic assay: critical protocol features, studies with nonylphenols, comparison with a yeast estrogenicity assay. Regul. Toxicol. Pharmacol. 26, 176-188 (1997).
10. C. H. Carlisle and D. Crowfoot, A determination of molecular symmetry in the ab-diethyldibenzyl series. J. Chem. Soc. 6-9 (1941).
11. S. G. Lundeen, J. M. Carver, M.-L. McKean and R. C. Winneker, Characterisation of the ovariectomised rat model for the evaluation of estrogen effects on plasma cholesterol levels. Endocrinology 138, 1552-1558 (1997).